Advertisement
Screener

Oncotelic Therapeutics, Inc. (OTLC) Preferred Stock, Shares Authorized

2.8 / 5 stars · 68/120 Roast Me

Oncotelic Therapeutics, Inc. Preferred Stock, Shares Authorized

Oncotelic Therapeutics, Inc. (OTLC) had Preferred Stock, Shares Authorized of 15.00 million shares as of 2026-06-30, per its 10-Q filed 2026-08-13.

Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Preferred Stock, Number of Shares, Par Value and Other Disclosure

us-gaap:PreferredStockSharesAuthorized · last filed 2026-08-13

  • 2026-06-30: Preferred Stock, Shares Authorized 15.00M shares.
  • 2026-03-31: Preferred Stock, Shares Authorized 15.00M shares.
  • 2025-12-31: Preferred Stock, Shares Authorized 15.00M shares.
  • 2024-12-31: Preferred Stock, Shares Authorized 15.00M shares.
Period endPreferred Stock, Shares Authorized
2026-06-3015.00M shares
10-Q · filed 2026-08-13
2026-03-3115.00M shares
10-Q · filed 2026-05-14
2025-12-3115.00M shares
10-Q · filed 2026-08-13
2024-12-3115.00M shares
10-K · filed 2026-04-15
2024-03-3115.00M shares
10-Q · filed 2024-05-15
2023-12-3115.00M shares
10-Q · filed 2024-05-15
2023-03-3115.00M shares
10-Q · filed 2023-05-22
2022-12-3115.00M shares
10-Q · filed 2023-05-22
2022-09-3015.00M shares
10-Q · filed 2022-11-18
2022-06-3015.00M shares
10-Q · filed 2022-08-22
2022-03-3115.00M shares
10-Q · filed 2022-05-23
2021-12-3115.00M shares
10-K/A · filed 2023-04-20
2021-09-3015.00M shares
10-Q · filed 2021-11-22
2021-06-3015.00M shares
10-Q · filed 2021-08-20
2021-03-3115.00M shares
10-Q · filed 2021-05-24
2020-12-3115.00M shares
10-K · filed 2022-04-15
2020-09-3015.00M shares
10-Q · filed 2020-11-16
2020-06-3015.00M shares
10-Q · filed 2020-08-14
2020-03-3115.00M shares
10-Q · filed 2020-06-29
2019-12-3115.00M shares
10-K · filed 2021-04-15
2019-09-3015.00M shares
10-Q · filed 2019-11-19
2019-06-3015.00M shares
10-Q · filed 2019-08-19
2019-03-3115.00M shares
10-Q · filed 2019-05-15
2018-12-3115.00M shares
10-K · filed 2020-05-14
2018-09-3015.00M shares
10-Q · filed 2018-11-14
2018-06-3015.00M shares
10-Q · filed 2018-08-14
2018-03-3115.00M shares
10-Q · filed 2018-05-14
2017-12-3115.00M shares
10-K · filed 2019-04-10
2017-09-3015.00M shares
10-Q · filed 2017-11-14
2017-06-3015.00M shares
10-Q · filed 2017-08-02
2017-03-3115.00M shares
10-Q · filed 2017-05-08
2016-12-3115.00M shares
10-K · filed 2018-04-17
2016-09-3015.00M shares
10-Q · filed 2016-11-14
2016-06-3015.00M shares
10-Q · filed 2016-08-02
2016-03-3115.00M shares
10-Q · filed 2016-05-06
2015-12-3115.00M shares
10-K · filed 2017-03-30
2015-09-3015.00M shares
10-Q · filed 2015-11-12
2015-06-3015.00M shares
10-Q · filed 2015-08-06
2015-03-3115.00M shares
10-Q · filed 2015-05-07
2014-12-3115.00M shares
10-K · filed 2016-03-25
2014-09-3015.00M shares
10-Q · filed 2014-11-13
2014-06-3015.00M shares
10-Q · filed 2014-08-08
2014-03-3115.00M shares
10-Q · filed 2014-05-08
2013-12-3115.00M shares
10-K · filed 2015-03-30
2013-09-3015.00M shares
10-Q · filed 2013-11-13
2013-06-3015.00M shares
10-Q/A · filed 2013-10-18
2013-03-3115.00M shares
10-Q · filed 2013-05-09
2012-12-3115.00M shares
10-K · filed 2014-03-20
2012-09-3015.00M shares
10-Q · filed 2012-11-09
2012-06-3015.00M shares
10-Q · filed 2012-08-13
2012-03-3115.00M shares
10-Q · filed 2012-05-11
2011-12-3115.00M shares
10-K · filed 2013-03-15
2011-09-3015.00M shares
10-Q · filed 2011-11-10
2011-06-3015.00M shares
10-Q · filed 2011-08-12
2010-12-3115.00M shares
10-K · filed 2012-03-28